A MULTICENTER, SINGLEARM PROSPECTIVE PHASE 3 STUDY TO EVALUATE SAFETY AND EFFICACY OF GLECAPREVIR/ PIBRENTASVIR 8-WEEK TREATMENT IN ADULTS WITH ACUTE HEPATITIS C VIRUS INFECTION


Por: Llibre, JM, Lank, P, Miller, M, Fredrick, L, Welhaven, A, Semizarov, D, Marcinak, J, Gordon, S, Moon, J, Baumgarten, A and Workowski, K

Publicada: 1 feb 2025
Resumen:


Filiaciones:
:
 Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

Lank, P:
 AbbVie Inc, N Chicago, IL USA

Miller, M:
 AbbVie Inc, N Chicago, IL USA

Fredrick, L:
 AbbVie Inc, N Chicago, IL USA

Welhaven, A:
 AbbVie Inc, N Chicago, IL USA

Semizarov, D:
 AbbVie Inc, N Chicago, IL USA

Marcinak, J:
 AbbVie Inc, N Chicago, IL USA

Gordon, S:
 Henry Ford Hlth Syst, Detroit, MI USA

Moon, J:
 Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

Baumgarten, A:
 Ctr Infectiol, Atlanta, GA USA

Workowski, K:
 Emory Univ, Sch Med, Atlanta, GA 30322 USA
ISSN: 02709139





Hepatology
Editorial
John Wiley & Sons Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 81 Número: 2
Páginas: 74-75
WOS Id: 001676764400031

MÉTRICAS